The Results of ACES (Antihypertensive Combinations’ Long Term Efficacy Comparing Study): Analysis of Metabolic Effects of Antihypertensive Combination Therapies

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical drug investigation

• Publication date

  2016-07-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40261-016-0431-xPMID 27405983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combination Therapy in Hypertension: What Are the Best Options According to Clinical Pharmacology Principles and Controlled Clinical Trial Evidence?

  2015cited by this paper
• Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension.

  2014cited by this paper
• NICE clinical guideline 127: Hypertension: Clinical management of primary hypertension in adults

  2012cited by this paper
• Lipid Effects of Antihypertensive Medications

  2012cited by this paper
• Clinical Positioning of Indapamide Sustained Release 1.5mg in Management Protocols for Hypertension

  2012cited by this paper
• Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

  2009cited by this paper
• Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

  2009cited by this paper
• Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients

  2009cited by this paper
• The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.

  2009cited by this paper
• Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: results of the STAR-LET study.

  2008cited by this paper
• Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

  2008cited by this paper
• Differences in Glucose Tolerance Between Fixed-Dose Antihypertensive Drug Combinations in People With Metabolic Syndrome

  2007cited by this paper
• Beta-Blockers for the Treatment of Essential Hypertension: What are the Arguments Against Their Use as First Line Therapy?

  2007cited by this paper
• Errata

  2007cited by this paper
• Carvedilol: molecular and cellular basis for its multifaceted therapeutic potential.

  2006cited by this paper
• Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri

  2005cited by this paper
• An overview of the pharmacology and clinical efficacy of indapamide sustained release

  2005cited by this paper
• Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial

  2004cited by this paper
• Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.

  2004cited by this paper
• Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

  2004cited by this paper
• Carvedilol: a nonselective beta blocking agent with antioxidant properties.

  2002cited by this paper
• Metabolic Profile of Indapamide Sustained-Release in Patients with Hypertension

  2001cited by this paper
• Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents?

  1998influential reference
• Metabolic and Cardiovascular Effects of Carvedilol and Atenolol in Non-Insulin-Dependent Diabetes Mellitus and Hypertension

  1997cited by this paper
• Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.

  1997cited by this paper
• Long-term effects on plasma lipids of diet and drugs to treat hypertension

  1996cited by this paper
• Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.

  1996cited by this paper
• Vascular protective effects of ACE inhibitors and calcium antagonists: Theoretical basis for a combination therapy in hypertension and other cardiovasular diseases

  1995cited by this paper
• Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance.

  1994cited by this paper

• Real-World Evaluation of the Efficacy and Tolerability of a Fixed-Dose Combination of Amlodipine and Indapamide in Patients Over 55 Years

  2025cites this paper
• Controlling blood pressure and progression of hypertension-dependent cardiovascular continuum by amlodipine and perindopril A single pill fixed‑dose combination: focus on endothelial dysfunction and metabolic risks

  2024cites this paper
• Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease—A Narrative Clinical Review

  2024cites this paper
• Beneficial Effects of a Perindopril/Indapamide Single-Pill Combination in Hypertensive Patients with Diabetes and/or Obesity or Metabolic Syndrome: A Post Hoc Pooled Analysis of Four Observational Studies

  2021cites this paper
• Effectiveness of Perindopril/Indapamide Single-Pill Combination in Uncontrolled Patients with Hypertension: A Pooled Analysis of the FORTISSIMO, FORSAGE, ACES and PICASSO Observational Studies

  2020cites this paper
• Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation

  2018cites this paper
• Lifestyle and related genetic variations influence susceptibility towards essential hypertension

  2018cites this paper
• Treatment with triple combination of atorvastatin, perindopril, and amlodipine in patients with stable coronary artery disease: A subgroup analysis from the PAPA-CAD study

  2018cites this paper
• 2-Methoxyestradiol causes matrix metalloproteinase 9-mediated transactivation of epidermal growth factor receptor and angiotensin type 1 receptor downregulation in rat aortic smooth muscle cells.

  2018cites this paper
• Vascular legacy beyond blood pressure control: benefits of perindopril/indapamide combination in hypertensive patients with diabetes

  2018cites this paper
• Adherence to Treatment, Safety, Tolerance, and Effectiveness of Perindopril/Amlodipine Fixed-Dose Combination in Greek Patients with Hypertension and Stable Coronary Artery Disease: A Pan-Hellenic Prospective Observational Study of Daily Clinical Practice

  2017cites this paper